Free Trial
ASX:PNR

Pantoro (PNR) Stock Price, News & Analysis

Pantoro logo

About Pantoro Stock (ASX:PNR)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
1.07 million shs
Average Volume
N/A
Market Capitalization
$935.83 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Pantoro Limited, together with its subsidiaries, engages in the gold mining, processing, and exploration activities in Western Australia. The company explores for gold and silver deposits. It holds interest in the Halls Creek Project that includes the Nicolsons Mine located in Kimberley Region of Western Australia. The company was formerly known as Pacific Niugini Limited and changed its name to Pantoro Limited in December 2015. Pantoro Limited was incorporated in 1986 and is based in West Perth, Australia.

Receive PNR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pantoro and its competitors with MarketBeat's FREE daily newsletter.

PNR Stock News Headlines

Pantoro Gold Ltd PNTOD
Here’s How to Claim Your Stake in Elon’s Private Company, xAI
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.
Pantoro Limited Releases Q3 FY 2025 Results
Pantoro Gold to Host Investor Update Webinar
See More Headlines

PNR Stock Analysis - Frequently Asked Questions

Pantoro Limited (ASX:PNR) released its earnings results on Thursday, March, 15th. The company reported $0.01 EPS for the quarter. Pantoro had a negative trailing twelve-month return on equity of 12.91% and a negative net margin of 21.49%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Pantoro investors own include bluebird bio (BLUE), Cummins (CMI), L3 Technologies (LLL), Argonaut Gold (AR), Athene (ATH), BELLUS Health (BLU) and Esperion Therapeutics (ESPR).

Company Calendar

Last Earnings
3/15/2018
Today
5/05/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Industry
Gold
Sub-Industry
Machinery
Current Symbol
ASX:PNR
CIK
N/A
Fax
N/A
Employees
11,200
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-49,310,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$229.43 million
Price / Cash Flow
5.40
Book Value
A$0.08 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
6,450,000,000
Free Float
N/A
Market Cap
$935.83 million
Optionable
Not Optionable
Beta
1.42
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (ASX:PNR) was last updated on 5/5/2025 by MarketBeat.com Staff
From Our Partners